Drug intelligence / Profile preview

Argovit

Development stage
Unknown
Lead developer
Vector-Vita
Modality
Nanoparticles → Drug Delivery Systems
Administration
Intrauterine, Oral, Intranasal, Topical, Foliar, Trunk Injection
01

Overview

Argovit is a specialized formulation of silver nanoparticles (AgNPs) typically stabilized with polyvinylpyrrolidone (PVP), with an average particle size of approximately 35 nm. It exhibits broad-spectrum antimicrobial (antibacterial, antiviral, and antifungal) and antineoplastic properties. In veterinary medicine, Argovit is utilized for treating reproductive and inflammatory disorders such as bovine purulent catarrhal endometritis and mastitis, where it acts as an efflux pump inhibitor to restore bacterial sensitivity to multiple classes of antibiotics. In aquaculture, it is used to prevent and reduce mortality from the White Spot Syndrome Virus (WSSV) in shrimp. For human health, Argovit has been investigated as a prophylactic mouthwash and nasal rinse to prevent SARS-CoV-2 infection among healthcare workers and as a chemoprotective agent to mitigate the genotoxicity of compounds such as cyclophosphamide and sodium arsenite. Additionally, it is applied in agriculture to manage devastating crop diseases, including Huanglongbing in citrus and Fusarium wilt in bananas, by reducing bacterial and fungal titers.

Brand names
Argovit
Other names
Argovit AgNPsArgovit silver nanoparticlesPVP-AgNPs Argovit

Beyond the preview

Go deeper on Argovit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Argovit.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call